Furthermore, the Bifidobacterium strain improves antitumor immune responses in mice with colon cancer by raising CD4+ and CD8+ T cells and NK cells and the CD4+/Treg, CD8+/Treg and effector CD8+/Treg ratios [51]. The gene discussed is CD8A; the disease is malignant colon neoplasm.